首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives
【24h】

Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives

机译:新型苄胺衍生物的合成及其碳酸酐酶同工酶I和II的抑制作用

获取原文
获取原文并翻译 | 示例
       

摘要

Synthesis and carbonic anhydrase inhibitory properties of novel diarylmethylamines 22-25 and sulfonamide derivatives 26-28 were investigated. Acylation of methoxy-substituted benzenes with benzene carboxylic acids, reduction of ketones with NaBH4, conversion of alcohols to azides, Pd-C catalyzed hydrogenation of azides afforded title compounds 22-25. Compounds 22, 24 and 25 were converted to sulfonamide derivatives 26-28 with MeSO2Cl. The inhibitory effects of novel benzylamine derivatives 22-28 were tested on human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes hCA I and II. The results demonstrated that compound 28 was found to be the best inhibitor against both hCA I (K-i: 3.68 mM) and hCA II (K-i: 9.23 mM).
机译:研究了新型二芳基甲胺22-25和磺酰胺衍生物26-28的合成及其碳酸酐酶抑制性能。甲氧基取代的苯与苯羧酸的酰化,NaBH4还原酮,醇转化为叠氮化物,Pd-C催化的叠氮化物氢化得到标题化合物22-25。用MeSO 2 Cl将化合物22、24和25转化为磺酰胺衍生物26-28。测试了新型苄胺衍生物22-28对人碳酸酐酶(hCA,EC 4.2.1.1)同工酶hCA I和II的抑制作用。结果表明,发现化合物28是针对hCA I(K-1:3.68mM)和hCA II(K-1:9.23mM)的最佳抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号